Wei D Ding, MBBS, PhD

  • 2188 Citations
  • 26 Scopus h-Index
19972019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Wei D Ding is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 0 Similar Profiles
B-Cell Chronic Lymphocytic Leukemia Medicine & Life Sciences
Human T-lymphotropic virus 1 Medicine & Life Sciences
Lymphocytosis Medicine & Life Sciences
Primate T-lymphotropic virus 1 Agriculture & Biology
NFATC Transcription Factors Medicine & Life Sciences
Bone Marrow Medicine & Life Sciences
B-Lymphocytes Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2011 2016

B-Cell Chronic Lymphocytic Leukemia
1-Phosphatidylinositol 4-Kinase
Research Personnel
Mentors
Stromal Cells

Research Output 1997 2019

  • 2188 Citations
  • 26 Scopus h-Index
  • 53 Article
  • 5 Letter
  • 2 Conference contribution
  • 1 Review article

Addition of venetoclax at time of progression in ibrutinib-treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare

Hampel, P. J., Call, T. G., Ding, W., Muchtar, E., Kenderian, S. S., Wang, Y., Leis, J. F., Witzig, T. E., Koehler, A. B., Fonder, A. L., Schwager, S. M., Rabe, K. G., Van Dyke, D. L., Braggio, E., Slager, S. L., Kay, N. E. & Parikh, S. A., Jan 1 2019, (Accepted/In press) In : American journal of hematology.

Research output: Contribution to journalLetter

Open Access

Identification of factors associated with duplicate rate in ChIP-seq data

Tian, S., Peng, S., Kalmbach, M., Gaonkar, K. S., Bhagwate, A., Ding, W. D., Eckel-Passow, J. E., Yan, H. D. & Slager, S. L., Apr 1 2019, In : PloS one. 14, 4, e0214723.

Research output: Contribution to journalArticle

Open Access
Chromatin Immunoprecipitation
Polymerase chain reaction
Chromatin
chromatin
polymerase chain reaction

IGH translocations in chronic lymphocytic leukemia: Clinicopathologic features and clinical outcomes

Fang, H., Reichard, K. K., Rabe, K. G., Hanson, C. A., Call, T. G., Ding, W. D., Kenderian, S., Muchtar, E., Schwager, S. M., Leis, J. F., Chanan Khan, A. A., Slager, S. L., Braggio, E. D., Smoley, S. A., Kay, N. E., Shanafelt, T. D., Van Dyke, D. L. & Parikh, S. A., Jan 1 2019, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Survival
Therapeutics
Databases
1 Citation (Scopus)

Probable Invasive Pulmonary Cryptococcosis and Possible Cryptococcal Empyema in CLL Treated With Frontline Ibrutinib

Koehler, A. B., Vijayvargiya, P. & Ding, W., May 2019, In : Mayo Clinic proceedings. 94, 5, p. 915-917 3 p.

Research output: Contribution to journalLetter

Open Access
Cryptococcosis
Empyema
Lung
PCI 32765
2 Citations (Scopus)

Rapid disease progression following discontinuation of ibrutinib in patients with chronic lymphocytic leukemia treated in routine clinical practice

Hampel, P. J., Ding, W. D., Call, T. G., Rabe, K. G., Kenderian, S., Witzig, T. E., Muchtar, E., Leis, J. F., Chanan Khan, A. A., Koehler, A. B., Fonder, A. L., Schwager, S. M., Slager, S. L., Shanafelt, T. D., Kay, N. E. & Parikh, S. A., Jan 1 2019, In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Disease Progression
Clinical Trials
PCI 32765
Therapeutics